Stay updated on ACTT: Remdesivir for Severe COVID-19 Clinical Trial

Sign up to get notified when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now shows an updated ClinicalTrials.gov interface revision (from v3.5.2 to v3.5.3). This reflects a minor platform/version update rather than a change to the study record content.
    Difference
    0.0%
    Check dated 2026-04-27T07:38:23.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-20T03:15:56.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-22T08:31:35.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a minor version update and does not alter the study details or page content.
    Difference
    0.0%
    Check dated 2026-03-07T19:32:17.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2.
    Difference
    0.0%
    Check dated 2026-02-14T04:47:28.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Revision updated: added v3.4.1 and removed v3.4.0.
    Difference
    0.0%
    Check dated 2026-02-06T20:41:05.000Z thumbnail image

Stay in the know with updates to ACTT: Remdesivir for Severe COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.